吸入药物递送:健康肺插管患者的随机研究
该随机研究纳入31例健康肺的术后神经外科插管患者,比较四种振动网孔雾化器配置的放射性气溶胶肺沉积。专用气溶胶治疗回路(SCAT)组肺沉积为名义剂量的19.7%(14.0–24.5),是其他三组的2–3倍(p < 0.01),且内、外肺区剂量均显著增加(p < 0.01),但第四组右外肺区因药物沿气管优先流入右支气管而例外;加热湿化器关闭或开启时肺沉积相似;体外吸入剂量与肺剂量相关(R=0.768,p<0.001)。作者认为优化给药技术可显著增加肺内(包括外周气道)药物递送,但需进一步研究评估其对患者结局的影响。
要点
- SCAT组肺沉积为名义剂量19.7%(14.0–24.5),是其他三组的2–3倍(p < 0.01)。
- SCAT组内、外肺区药物剂量均显著增加(p < 0.01),第四组右外肺区例外。
- 加热湿化器关闭30 min或保持开启,肺沉积相似。
- 所有组约50–60%肺剂量到达双肺外区。
- 体外吸入剂量与肺剂量相关(R=0.768,p<0.001)。
适用人群与场景
- 31例健康肺的术后神经外科插管患者。
处置流程与药物剂量
- 使用振动网孔雾化器和特定呼吸机设置进行气溶胶递送,随机分为四种配置。
- 配置1:专用气溶胶治疗回路(SCAT),雾化器置于Y形接头30 cm处。
- 配置2:加热湿化回路在雾化前30 min关闭。
- 配置3:加热湿化回路保持开启,雾化器置于加热湿化器入口。
- 配置4:常规回路,雾化器置于热湿交换过滤器与气管导管之间。
研究设计与关键结果
- SCAT组肺沉积达名义剂量19.7%(14.0–24.5),其他三组为2–3倍更低(p < 0.01)。
- 所有组约50–60%肺剂量到达双肺外区。
- SCAT组内、外肺区药物剂量均显著增加(p < 0.01),但第四组右外肺区例外,因药物从气管导管和气管优先流入右支气管。
- 加热湿化器关闭或开启时肺沉积相似。
- 体外吸入剂量与肺剂量相关(R=0.768,p<0.001)。
证据类型、等级与局限
- 随机研究,样本量31例,健康肺插管患者。
- 局限:作者指出在调整机械通气前,需进一步研究继续优化并评估其对药物递送和患者结局的影响。
对床旁实践的改变
- 作者认为优化给药技术可显著增加肺内(包括外周气道)药物递送。
- 作者指出在调整机械通气前,需进一步研究评估优化技术对药物递送和患者结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The administration technique for inhaled drug delivery during invasive ventilation remains debated. This study aimed to compare in vivo and in vitro the deposition of a radiolabeled aerosol generated through four configurations during invasive ventilation, including setups optimizing drug delivery.
METHODS: Thirty-one intubated postoperative neurosurgery patients with healthy lungs were randomly assigned to four configurations of aerosol delivery using a vibrating-mesh nebulizer and specific ventilator settings: (1) a specific circuit for aerosol therapy (SCAT) with the nebulizer placed at 30 cm of the wye, (2) a heated-humidified circuit switched off 30 min before the nebulization or (3) left on with the nebulizer at the inlet of the heated-humidifier, (4) a conventional circuit with the nebulizer placed between the heat and moisture exchanger filter and the endotracheal tube. Aerosol deposition was analyzed using planar scintigraphy.
RESULTS: A two to three times greater lung delivery was measured in the SCAT group, reaching 19.7% (14.0-24.5) of the nominal dose in comparison to the three other groups (p < 0.01). Around 50 to 60% of lung doses reached the outer region of both lungs in all groups. Drug doses in inner and outer lung regions were significantly increased in the SCAT group (p < 0.01), except for the outer right lung region in the fourth group due to preferential drug trickling from the endotracheal tube and the trachea to the right bronchi. Similar lung delivery was observed whether the heated humidifier was switched off or left on. Inhaled doses measured in vitro correlated with lung doses (R = 0.768, p < 0.001).
CONCLUSION: Optimizing the administration technique enables a significant increase in inhaled drug delivery to the lungs, including peripheral airways. Before adapting mechanical ventilation, studies are required to continue this optimization and to assess its impact on drug delivery and patient outcome in comparison to more usual settings.
参考来源
- Dugernier J, Le Pennec D, Maerckx G, et al. Inhaled drug delivery: a randomized study in intubated patients with healthy lungs. Ann Intensive Care. 2023. PMID: 38072870. doi:10.1186/s13613-023-01220-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。